1. Home
  2. GBIO vs JVA Comparison

GBIO vs JVA Comparison

Compare GBIO & JVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • JVA
  • Stock Information
  • Founded
  • GBIO 2016
  • JVA 1971
  • Country
  • GBIO United States
  • JVA United States
  • Employees
  • GBIO N/A
  • JVA N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • JVA Packaged Foods
  • Sector
  • GBIO Health Care
  • JVA Consumer Staples
  • Exchange
  • GBIO Nasdaq
  • JVA Nasdaq
  • Market Cap
  • GBIO 29.2M
  • JVA 24.7M
  • IPO Year
  • GBIO 2020
  • JVA 2005
  • Fundamental
  • Price
  • GBIO $0.38
  • JVA $4.40
  • Analyst Decision
  • GBIO Strong Buy
  • JVA
  • Analyst Count
  • GBIO 4
  • JVA 0
  • Target Price
  • GBIO $7.33
  • JVA N/A
  • AVG Volume (30 Days)
  • GBIO 1.1M
  • JVA 237.1K
  • Earning Date
  • GBIO 08-06-2025
  • JVA 06-13-2025
  • Dividend Yield
  • GBIO N/A
  • JVA N/A
  • EPS Growth
  • GBIO N/A
  • JVA 856.08
  • EPS
  • GBIO N/A
  • JVA 0.65
  • Revenue
  • GBIO $24,556,000.00
  • JVA $84,651,329.00
  • Revenue This Year
  • GBIO N/A
  • JVA N/A
  • Revenue Next Year
  • GBIO N/A
  • JVA N/A
  • P/E Ratio
  • GBIO N/A
  • JVA $6.63
  • Revenue Growth
  • GBIO 146.47
  • JVA 15.86
  • 52 Week Low
  • GBIO $0.30
  • JVA $1.50
  • 52 Week High
  • GBIO $3.65
  • JVA $9.93
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 49.21
  • JVA 54.03
  • Support Level
  • GBIO $0.32
  • JVA $4.15
  • Resistance Level
  • GBIO $0.36
  • JVA $4.54
  • Average True Range (ATR)
  • GBIO 0.03
  • JVA 0.27
  • MACD
  • GBIO 0.00
  • JVA -0.02
  • Stochastic Oscillator
  • GBIO 64.67
  • JVA 38.10

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

Share on Social Networks: